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It is important to understand the quality of health care for racial and ethnic minorities 
covered under the largest U.S. government-run insurance program, Medicare, because the 
demographics of the U.S. are becoming older and more diverse. A new value-based program 
under Medicare is the Shared Savings Program (MSSP), which creates incentives to improve 
care quality and health outcomes for Medicare beneficiaries with a specific focus on increasing 
the provision of preventive care services. This capstone project aims to understand the 
representation of racial/ethnic minority Medicare beneficiaries, namely African 
Americans/Blacks and Hispanics/Latinxs, that receive care from providers or facilities (i.e., 
Accountable Care Organizations [ACOs]) participating in the MSSP, as well as their 
representation in ACOs with the highest quality measure performance scores on colorectal 
cancer screening and breast cancer screening – two important preventive health services. Upon 
analyzing publically available data on the entire Medicare program and MSSP ACOs, the results 
indicated that the representation of African Americans/Blacks and Hispanics/Latinxs in MSSP 
ACOs was less than their representation in the entire Medicare program, as well as less in ACOs 
with top performance in both of the cancer screening preventive health measures.  Being aware 
of the reach of the MSSP among racial/ethnic minority populations may help policy makers and 
health care organizations address barriers and establish effective strategies for racial/ethnic 
minority participation in the MSSP and other value-based care programs in an effort to, 
ultimately, promote health equity and eliminate current overarching disparities in quality of care 
and health outcomes that exist within these populations. 
Keywords: MSSP, accountable care organizations, value-based care, race, ethnicity, health 
disparities, breast cancer screening, colorectal cancer screening 
L. Arneson   Capstone (CPH 529) - Fall 2019 
2 
 
Chapter 1 - Introduction 
Significance & Aim 
With the United States becoming an older and more racially/ethnically diverse country, 
there is a persistent need to focus on improving the quality and cost of health care for these 
specific populations. Research shows that the aged and racial/ethnic minority populations 
manage more complex and chronic health conditions, resulting in higher mortality rates and costs 
of health care services. Mainly because of these concerns, the federal government has begun to 
reform health care delivery and payment with its largest program, Medicare, through the use of 
value-based programs that incentivize higher quality care and lower medical costs, specifically 
by rewarding providers whom ensure beneficiaries are receiving efficient and accessible 
preventive care services instead of inefficient and expensive hospital or emergency department 
services. One of these trademark Medicare value-based programs, launched on 2012, is the 
Medicare Shared Savings Program (MSSP).  
However, the overall Medicare program does not specifically target racial/minority 
populations as much as it specifically targets the aged population through automatic eligibility 
for coverage of those over age 65, so it would be enlightening to see how racial/ethnic minorities 
are currently represented in a large value-based Medicare program like the MSSP. To understand 
this representativeness, the Reach dimension of the RE-AIM theoretical framework was applied 
for this capstone through statistical comparison of proportions. The RE-AIM framework is well-
known and used to analyze the impact of public health interventions, which for this capstone, is 
the MSSP.  
 
 




The first research question for this capstone involved comparing the Reach of the entire 
Medicare system to the MSSP: 
1. What is the representation (i.e., proportion) of African American/Black and 
Hispanic/Latinx beneficiaries in all MSSP ACOs compared to the proportion of 
African American/Black and Hispanic/Latinx beneficiaries in the entire Medicare 
population? 
The current literature on health disparities, discussed in the next chapter, predominantly 
reports that racial/ethnic minorities – specifically African Americans/Blacks and 
Hispanics/Latinxs – receive less preventive care, have worse overall quality of health care 
services, and experience poorer health outcomes. With this literature in mind, I hypothesized that 
the representation of African Americans/Blacks and Hispanics/Latinxs is lower in the MSSP 
compared to their overall representation in the entire Medicare program, since this specific 
program is known for providing higher quality care to improve beneficiary health outcomes. For 
the first research question, I aimed to see whether there was enough evidence to support my 
hypothesis that the proportion of African American/Black and Hispanic/Latinx beneficiaries in 
the entire Medicare population is greater than the proportion of African American/Black and 
Hispanic/Latinx beneficiaries in all MSSP ACOs. 
The second research question is two-fold and compared all MSSP ACOs to those that 
have highest performance on two preventive health quality measures in which ACOs are 
required to report to receive incentive payments: 
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2. What is the proportion of African American/Black and Hispanic/Latinx beneficiaries 
in ACOs that achieved the highest performance on (a) Colorectal Cancer Screening 
and (b) Breast Cancer Screening compared to the proportion of African 
American/Black and Hispanic/Latinx beneficiaries in all MSSP ACOs? 
Racial/ethnic minority health disparities literature highlights that African American/Black 
and Hispanic/Latinx patients receive less frequent cancer screenings and also have higher 
incidence and mortality rates from certain types of cancers. Because of these findings, I 
hypothesized that the representation of African Americans/Blacks and Hispanics/Latinxs is lower 
in MSSPs that have the highest performance scores on both the preventive health quality 
measures for colorectal cancer screenings and breast cancer screenings compared to their overall 
representation in the MSSP. For both parts of this research question, I aimed to see whether there 
was enough evidence to support my hypothesis that the proportion of African American/Black 
and Hispanic/Latinx beneficiaries in all MSSP ACOs is greater than the proportion of African 
American/Black and Hispanic/Latinx beneficiaries in the MSSP ACOs that achieved the highest 
performance scores on colorectal cancer screening and breast cancer screening measures. 
Chapter 2 – Background and Literature Review 
The United States’ Aging and Chronically Ill Population  
The United States of America is becoming a nation with a larger aged population. 
According to the Census Bureau, the largest population age group in the U.S. – The Baby 
Boomers (i.e., those born between World War II and the early 1960s) – will all be older than 65 
by 20301. A report compiled by the National Institutes of Health and the World Health 
Organization attributes the rapidly aging population to advancements in medical care, 
L. Arneson   Capstone (CPH 529) - Fall 2019 
5 
 
technology, and living conditions, which have resulted in a global shift in leading causes of death 
from infectious and acute diseases to chronic and non-infectious diseases and, subsequently, 
increased life expectancy2. Despite life expectancy improvements, the changing demographics of 
the U.S. will have adverse implications on all of society’s institutions, especially the health care 
system.  
As a person progresses in age, their body system becomes frailer and they tend to be 
diagnosed with more chronic health conditions. About 60% of the aging population is likely to 
be managing at least one chronic condition, such as cancer, arthritis, diabetes, heart disease, 
stroke, and dementia3. It is highly likely that there will be a significant rise in the number of 
people diagnosed with cancer, with the number of new cancer cases projected to increase from 
17 million in 2020 to 27 million in 2030 and number of cancer survivors to increase from 15.5 
million in 2016 to 26.1 million in 20402,4.  
The increase in chronic diseases, like cancer, among the aging population are already 
coming with individual and societal implications. Individuals living with one or more chronic 
diseases deal with vast daily limitations, along with the need for more medical treatments and 
lifestyle adjustments to manage the disease which expend personal time and financial costs5-7. In 
terms of financial costs to society, costs associated with chronic diseases are already profound, 
totaling up $1.1 trillion or almost 6% of the country’s gross domestic product in 20168. It is 
anticipated that there will be twice as many hospital inpatient admissions and outpatient 
physician visits by Baby Boomers by 2030, which will be costly in time for health care providers 
and financially costly for health care payers9. Specifically, the National Cancer Institute 
anticipates that the costs of cancer care will reach about $174 billion in the next year and it is 
easy to imagine that this number will likely increase in the coming years10. 
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The expanding aging population is retiring at record numbers – approximately 10,000 
each day11. These retirees will inevitably be shifting off private employer-based insurance and 
becoming eligible to enroll in Medicare since hitting age 65 is currently one of the eligibility 
criteria for Medicare coverage, regardless of race/ethnicity, income, or U.S. geographic location. 
Enrollment in Medicare – a health insurance program administered solely by the federal 
government – is expected to cover over 80 million beneficiaries by 2030, which is almost double 
the number of beneficiaries in 2010, and that number is anticipated to continuously rise in the 
decades to follow12. This increase in Medicare enrollment is displayed in Figure 1 based on data 
from the 2013 Annual Report of the Board of Trustees of the Federal Hospital Insurance and 
Federal Supplementary Trust Funds. 
 
 
The federal government and taxpayers are already seeing the financial impacts of this 
shift in public insurance coverage of more older and chronically ill patients, with the total 
amount of Medicare benefit payments increasing from $462 billion in 2008 to $731 billion in 



































Figure 1: Projected Change in Medicare Enrollment (in 
millions), 2000-2050
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costs ranging from $378 to $1,792 for beneficiaries with one to five or more chronic disease, 
respectively7. With a rapidly aging population and costly chronic disease care, health care 
delivery will need to be attuned to address growing utilization of health care that will be 
predominantly reimbursed by Medicare.  
Racial/Ethnic Minority Health Disparities 
The U.S. is also becoming a more racially/ethnically diverse nation. White Americans are 
currently considered the majority at 72.6% of the population but other U.S. Census-classified 
racial and ethnic minority groups – African American/Black, Hispanic/Latinx, American Indian 
and Alaska Native, Asian American, and Native Hawaiian and Other Pacific Islanders – are 
growing13. The Census Bureau projects that by 2045, those in the U.S. that identify as White will 
become a minority racial/ethnic group at 49.7% of the population, whereas racial/ethnic minority 
groups will cumulatively become the majority, with Hispanics/Latinxs at 24.6%, African 
Americans/Blacks at 13.1%, Asian Americans at 7.9%, and 3.8% for those with more than one 
race14.  
With a rapidly growing racial/ethnic minority population in the U.S., we should all 
continue to hone in on the root causes of persistent health disparities that exist among these 
minority groups. The root causes of racial/ethnic health inequities are largely related to 
socioeconomic factors outside of the four walls of a clinic or hospital, such as discrimination, 
lack of access to quality education, mistreatment in the criminal justice system, insufficient 
income and employment opportunities, unsafe living and working environments, and minimal to 
no access to healthy food, transportation, and/or areas for physical activity15-18. In succession of 
these factors being prevalent among racial/ethnic minorities, these groups face obstacles in 
accessing the health care system, which is likely connected to them subsequently receiving less 
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preventive care, having worse overall quality of health care services, and experiencing poorer 
health outcomes19-23. 
Specifically, one study found that out of five significant preventive primary care services 
delivered to aged Medicare beneficiaries (age 65+) – colorectal cancer screening, influenza 
vaccination, lipid screening, mammography (breast cancer screening), and Papanicolaou smear 
(cervical cancer screening) – there were lower rates of each of these five services for both 
African Americans/Blacks and Hispanic/Latinxs compared to Whites. Further, when the 
researchers of this study accounted for factors such as income, education level, and health status, 
the disparities of services between the two racial/ethnic minority groups and Whites grew 
wider24. 
Along with being less likely to receive effective health care services, racial/ethnic 
minorities are also more susceptible to receiving low-value, costly care. A study in 2017 using 
Medicare administrative data from 2006 through 2011 found that African American/Black and 
Hispanic/Latinx beneficiaries had directionally similar odds of receiving more low-value and 
unnecessary services than White beneficiaries, including cardiac screening, pre-surgery cardiac 
testing, bone density screening, and opioid or butal bital prescriptions for migraines25. 
Additionally, the study found that a greater number of outpatient clinician visits were associated 
with higher rates of low-value care for five services among African American/Black 
beneficiaries and six services among Hispanic/Latinx beneficiaries. 
Research has compatibly shown significant racial/ethnic differences in the frequency and 
timing of cancer screening and treatment, specifically among Hispanic/Latinx and Black/African 
American patients. According to data collected by the Centers for Disease Control and 
Prevention (CDC) through the Behavioral Risk Factor Surveillance System Survey, the 
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percentage of respondents aged 50–75 years who reported receiving a colorectal cancer 
screening (either a fecal occult blood test within 1 year or colonoscopy within 10 years) was 
lowest for Hispanics/Latinxs at 51.2%, with African Americans/Blacks reporting higher than 
Hispanic/Latinxs at 62.9% but less than Whites at 66.2%26. Lower screenings for colorectal 
cancer have also been attributed to African American/Black patients27. One analysis of Medicare 
claims data found that colorectal cancer screenings were lower among African American/Black 
beneficiaries compared to Whites, with respective screening rates of 39.0% and 48.0%28.  
A 2017 study conducted by the American Cancer Society found that for African 
Americans/Blacks that did receive a colorectal cancer screening (colonoscopy), they were more 
likely than Whites to receive this screening from less skilled health care providers29. In terms of 
breast cancer screening, one study analyzing mammography (breast cancer screening) registry 
data found that both African American/Black and Hispanic/Latina women were more likely than 
White women to have inadequate screenings30. Another study of the Medicare Surveillance, 
Epidemiology, and End Results database to compare diagnostic, treatment, and clinical delay 
among women diagnosed with breast cancer found that African American/Black women enrolled 
in Medicare had the highest percentage with a delay of diagnosis of two months or more at 
22.1%, followed by White women (18.3%), and then Hispanic/Latina women (18.0%)31.   
Cancer is one of the leading causes of deaths in the U.S. and there are evident disparities 
in incidence and mortality rates among the two largest racial/ethnic minority populations – 
African American/Blacks and Hispanic/Latinxs – compared to White populations, which are 
likely connected to differences in screening and treatment. Most notably, extensive research has 
shown that African American/Black women are diagnosed with more advanced stages of breast 
cancer and are almost twice as likely as to die of breast cancer compared to White women, with a 
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40% higher mortality rate32-34. Additionally, compared to all racial/ethnic groups, African 
Americans/Blacks have higher mortality rate of colorectal cancer and are also diagnosed with 
later stages of the disease35-37. Specifically, African American/Black men have a 5-year survival 
rate of colorectal cancer at 55.7% compared to White men having a 65.6% 5-year survival rate38. 
According to the American Cancer Society, nearly 1 in 3 African American/Black men and 
women will be diagnosed with cancer and about 1 in 5 will die from it36. Hispanics/Latinxs have 
been shown to have lower rates of cancer incidence and mortality; however, research has shown 
that they are more likely to be diagnosed with more advanced stages of cancers compared to 
Whites39. In 2018, breast cancer was estimated as the leading cause of cancer deaths and had the 
highest amount of new cancer cases for Hispanic/Latina women40.   
Differences in care quality and health outcomes among racial/ethnic minority groups, 
specifically among the two largest groups – Hispanics/Latinxs and African Americans/Blacks – 
highlights a critical need to focus on equity in the provision of high quality preventive care for 
salient chronic diseases such as cancer. Improving care and outcomes among racial/ethnic 
minorities could have profound effects not only on patients’ quality of life and burden of death, 
but also on financial costs throughout the health care system. A 2009 Urban Institute estimated 
that the Medicare program could save $15.6 billion per year if health disparities in preventable 
diseases among the Hispanic/Latinx and African American/Black communities were reduced41. 
These possibilities should be an acute focus for all stakeholders looking to improve the U.S. 
health care system.  
U.S. Health Care and Policy Reform 
Although the U.S. is considered one of the most medically-advanced countries in the 
world, it spends the most money on its health care system yet presents with some of the worst 
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health outcomes. According to the Organization for Economic Cooperation and Development 
2016 data comparing the U.S. and thirty-three countries, the U.S. spends about 17.2% of its GDP 
on health care, which is nearly half as much as the OECD country GDP median of 8.9%42-43.  
Despite the U.S. allotting a large amount of money into health care, utilization and 
outcomes – especially among racial/ethnic minorities – are poor. The National Academies 
Institute of Medicine found that compared to sixteen other high-income countries, the U.S. has 
higher rates of chronic conditions, such as heart disease, diabetes, and obesity, along with lower 
overall life expectancy44. Additionally, the U.S. has significantly large populations that are 
uninsured or are insured but face difficulties accessing health care due to various socioeconomic 
reasons. That is, many people are not able to afford health care services and resources to improve 
their health44. Most recently, the U.S. Census Bureau released a report that indicated the 
uninsured rate in the U.S. is beginning to rise again after steadily declining for a decade, with the 
percentage moving from 25.6 million in 2017 to 27.5 million in 201845. Americans have also 
self-reported worries about costs, with a recent survey showing that 85% of adults are concerned 
about their medical costs and 62% of those that rated their care as “poor” or “very poor” reported 
that, even with insurance coverage, their out-of-pocket healthcare costs have increased46.  
Based on these findings, increased investment in health policy and care delivery reform at 
the organizational and policy levels is truly unavoidable. Public and private sectors in the U.S. 
have recognized these issues in our current system and have been exploring ways to reduce the 
burdens of chronic diseases and health care costs. Primarily, they are working to transition the 
overall health care system to one less focused on volume of high cost treatments and procedures 
(i.e., fee-for-service [FFS]) to one focused more on higher quality, enhanced accessibility, and 
lower costs – known as value-based care.  
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Under the current Medicare FFS program, Medicare generally makes a separate payment 
to licensed providers for each item or service furnished to a beneficiary during treatment. 
Because the total payments received by a provider depends on the amount of items and services 
furnished to a beneficiary, there is an assumption that providers may feel financially incentivized 
to increase the volume of items and services unnecessarily to receive more payments47,48. 
Medicare FFS also seems to diminish an incentive for providers to invest in quality improvement 
and care coordination activities that could reduce the incidence of chronic conditions among 
patients because these activities would likely result in delivering less costly services, and thus, 
lower payments to providers.  
Value-based care shifts away from this paradigm by doing two main things 1) making 
providers more financially responsible for the cost and quality of care and 2) encouraging better 
coordination among providers and community partners to promote preventive care and reduce 
the amount of costly services needed within hospitals and clinics49-52. The Quadruple Aim – 
based off the Institute of Health’s Triple Aim – succinctly lists the main goals in the 
transformation towards value in health care: improved population health, enhanced patient 
experience, reduced cost of care, and increase provider satisfaction53.  
The Centers for Medicare and Medicaid Services (CMS) – the federal government 
agency that administers and regulates Medicare and other health programs – has spearheaded the 
reform efforts to fulfill the Quadruple Aim through the development of value-based care delivery 
and payment programs. This is due in large part to the fact that the U.S. federal government is 
quickly becoming the top purchaser of health care services with the rising coverage of the Baby 
Boomers under Medicare, so they are looking for ways to promote better providers and 
consumers to address the proliferating health care cost and quality concerns.  
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With the necessity for health care interventions that improve quality and lower costs for 
patients, value-based care programs administered by CMS have continued to develop. The move 
to push Medicare away from predominantly FFS reimbursement to value-based reimbursement 
accelerated with the passage of the Affordable Care Act of 2010 (ACA).   
Under authority granted by the ACA, the MSSP was launched in 2012. The MSSP is a 
value-based payment model in which groups of providers and facilities join together to form 
Accountable Care Organizations (ACO) to better coordinate patient care, reduce costs, and 
improve quality. ACO participants in the MSSP are collectively held responsible for all 
Medicare Part A (Hospital Insurance) and Part B (Medical Insurance) expenditures for an 
assigned population of Medicare FFS patients, as well as for performance on quality, utilization, 
and patient satisfaction measures54.  
For the 2016/2017 performance measurement reporting year, the MSSP ACO quality 
measures include the following domains: Patient/Caregiver Experience, Care 
Coordination/Patient Safety, Preventive Health, and At-Risk Population55. Participating ACOs 
are incentivized to achieve high performance scores on these quality measures because higher 
scores make them eligible to earn additional money (i.e., shared savings). Conversely, low 
performance – depending on the amount of financial risk the ACO voluntarily chooses to take on 
– can result in losing money (i.e., shared losses)54. The anticipated result of the MSSP over time 
is that participating providers and facilities will implement organizational-level interventions like 
efficient care coordination, robust data infrastructure, and promotion of preventive care services, 
because doing so will ensure higher performance scores and higher likelihood of earning shared 
savings56. Ultimately, these interventions should meet the vision of the Quadruple Aim and 
improve quality, costs, and outcomes for Medicare patients.   
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There are already results showing improved care and outcomes for ACOs participating in 
the MSSP since its inception seven years ago. The U.S. Department of Health and Human 
Services Office of Inspector General reported that in the first 3 years of the MSSP, ACOs 
improved performance on 82% of the individual quality measures, with a small set of high-
performing ACOs showing high performance on quality measures along with increased use of 
primary care preventive health services and reduced use of costly services like emergency 
department visits57. The report also showed that ACOs outperformed FFS providers on 81% of 
the quality measures. 
Understanding the Reach of the MSSP on Racial/Ethnic Minority Medicare Beneficiaries 
With a progressively aging population in the U.S. being covered by Medicare, the likely 
result is that more individuals – regardless of race/ethnicity, income, or geographic location – 
will be receiving care from ACOs participating in Medicare valued-based programs like the 
MSSP. All areas of the U.S. health care system, from providers in hospitals and clinics to payers 
like Medicare, will need to prepare for the many challenges of increased demand and address 
current challenges in massive disparities in care and outcomes through systemic improvements.  
The Preventive Health domain measures that MSSP ACOs are required to report and 
financially incentivized to perform well on focus on chronic conditions that disproportionately 
affect racial/ethnic minority populations. Most of the measures have to do with screenings, 
which are vital tools for early detection and reduction in premature deaths caused by chronic 
diseases. The CDC alleges that chronic diseases that could be avoided or managed through 
proper preventive health care services make up 75% of U.S. health care spending and if everyone 
in the country received recommended clinical preventive care, 100,000 lives could be saved each 
year58. ACOs quality performance is graded based on the percentage of each of these services 
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that are completed and documented by ACO providers, with 0.0 being the worst score and 100.0 
being the best score. Table 1 shows the nine Preventive Measures for the 2016/2017 MSSP 
quality performance reporting year55.  
Table 1: 2016/2017 Reporting Year MSSP ACO Quality 
Measures 
Preventive Care and Screening: Influenza Immunization 
Pneumonia Vaccination Status for Older Adults 
Preventive Care and Screening: Body Mass Index (BMI) 
Screening and Follow Up 
Preventive Care and Screening: Tobacco Use: Screening and 
Cessation Intervention 
Preventive Care and Screening: Screening for Clinical Depression 
and Follow-up Plan 
Colorectal Cancer Screening 
Breast Cancer Screening 
Preventive Care and Screening: Screening for High Blood 
Pressure and Follow-up Documented 
Statin Therapy for the Prevention and Treatment of Cardiovascular 
Disease 
 
Considering that more Medicare beneficiaries will be receiving care from ACO-
participating providers that are held accountable for performing well on these measures, they 
should expectantly begin to receive better preventive care as providers are incentivized to reduce 
incidence and mortality rates of certain chronic conditions. Focus on addressing preventive 
health care through increased screenings is a feature of performance measurement in value-based 
payment models like the MSSP and may be a beneficial intervention to address racial/ethnic 
health disparities in care for chronic conditions, like breast and colorectal cancer. 
Yet, analyzing the proportion of racial and ethnic minority patients that are receiving care 
under the MSSP appears to be minimal, with only a couple of studies specifically looking at 
ACO quality performance in the context of race and ethnicity. One study published in 2017 
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found that MSSP ACOs with a higher proportion of all racial/ethnic minority beneficiaries had 
worse quality performance on 26 out of 33 MSSP ACO performance measures59. Another study 
found that in eight rural Nebraska ACOs, White patients had higher colorectal cancer screening 
rates than racial/ethnic minority patients60. 
As the U.S. health care system implements novel efforts to incentivize providers to 
improve care quality and lower costs, these efforts should appropriately consider the current care 
experiences of racial/ethnic minority patients and work to address any existing inequities. The 
evaluation done for this capstone project is aimed to support these efforts by providing insight 
into how racial/ethnic disparities in care access and quality, particularly among the two largest 
racial/ethnic minority groups – Hispanics/Latinxs and African Americans/Blacks – are being 
addressed in our country’s largest public health insurance program. The information gleaned 
from this capstone may help researchers, policymakers, payers, and providers better understand 
the current accessibility of an extensive, value-based care intervention program on racial/ethnic 
minority Medicare beneficiaries, along with their receipt of two preventive care screenings for 
breast and colorectal cancer – two chronic conditions that disproportionately affect racial/ethnic 
minorities. 
Chapter 3 – Data and Methods 
Data Sources 
This capstone project involved conducting a cross-sectional analysis utilizing publicly 
available and non-individually identifiable secondary data from 2017. The publicly available 
data that was used for this capstone were two datasets released by CMS that include data on 
Medicare beneficiaries, ACOs, and the MSSP: 1) Total Medicare Enrollment: Part A and/or Part 
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B Enrollees, by Demographic Characteristics, Calendar Year 2017 File and 2) 2017 Shared 
Savings Program ACO Public Use File (PUF). 
The Total Medicare Enrollment: Part A and/or Part B Enrollees, by Demographic 
Characteristics, Calendar Year 2017 File includes data from 2017 on the entire Medicare FFS 
(i.e., Medicare Parts A and B) beneficiary population separated by the following demographic 
characteristics: age, sex, and race/ethnicity61. This dataset is available at 
https://www.cms.gov/Research-Statistics-Data-and-Systems/Statistics-Trends-and-
Reports/CMSProgramStatistics/2017/2017_Enrollment.html and can be exported as a Microsoft 
Excel file. 
The 2017 Shared Savings Program ACO PUF includes an updated list from 2017 of all 
472 ACOs participating in the MSSP and also includes the following data for each ACO, as 
applicable62: 
• Financial data (minimum loss rate, minimum sharing rate, and calculations of 
generated savings and losses) 
• Quality performance data (overall quality performance score and performance 
score on each of the 33 quality measures) 
• Demographic data on assigned ACO beneficiaries (age, sex, and race/ethnicity) 
• Data on expenditures and utilization  
• Data on providers and suppliers 
The 2017 Shared Savings Program ACO PUF is accessible at 
https://data.cms.gov/Special-Programs-Initiatives-Medicare-Shared-Savin/2017-Shared-Savings-
Program-SSP-Accountable-Care-O/gk7c-vejx and can be exported as a Microsoft Excel file. 




The research questions for this capstone investigated the Reach of the MSSP on racial/ 
ethnic minorities Medicare beneficiaries, specifically African American/Black and 
Hispanic/Latinx beneficiaries, using the first dimension of the RE-AIM framework. The RE-AIM 
theoretical framework is used to understand the public health impact of an intervention which, in 
this case, is the MSSP. Reach is defined as the “absolute number, proportion, and 
representativeness of individuals who are willing to participate in a given initiative63.” This 
capstone study assessed the Reach of the MSSP measuring proportion and using the two 
population proportion statistical test. This statistical test is used because the single variable of the 
research questions is race/ethnicity, which is a categorical variable. The proportions were 
calculated by dividing the total number of African American/Black and Hispanic/Latinx 
beneficiaries (numerator) by the total number of beneficiaries (denominator). The tests were one-
sided because I wanted to see if one proportion was higher or lower than the other proportion. To 
obtain the z-score and p-value for the two population proportion tests, the calculations were input 
into an online z-score calculator accessible at 
https://www.socscistatistics.com/tests/ztest/default2.aspx. The results of the two population 
proportion z-test were assessed using a significance level of p<0.05. If the p-values computed by 
the calculator were less than 0.05, then the null hypothesis would be rejected.  
Research Question 1 compared the proportion of African American/Black and 
Hispanic/Latinx beneficiaries in all MSSP ACOs to the proportion of African American/Black 
and Hispanic/Latinx beneficiaries in the entire Medicare population. 
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For the MSSP ACO population proportion, I extracted data from the 2017 Shared 
Savings Program ACO PUF. To calculate the total number of MSSP ACO assigned beneficiaries 
(denominator), I added up all of the numbers from six columns: 
• N_Ben_Race_White: Total assigned beneficiaries, Non-Hispanic White 
• N_Ben_Race_Black: Total assigned beneficiaries, Black 
• N_Ben_Race_Asian: Total assigned beneficiaries, Asian 
• N_Ben_Race_Hisp: Total assigned beneficiaries, Hispanic 
• N_Ben_Race_Native: Total assigned beneficiaries, North American Native 
• N_Ben_Race_Other: Total assigned beneficiaries, Other 
To calculate the total number of African American/Black and Hispanic/Latinx MSSP 
ACO assigned beneficiaries (numerator), I added up all of the data from two columns: 
N_Ben_Race_Black: Total assigned beneficiaries, Black and N_Ben_Race_Hisp: Total assigned 
beneficiaries, Hispanic. 
For the entire Medicare population proportion, I extracted data from the Total Medicare 
Enrollment: Part A and/or Part B Enrollees, by Demographic Characteristics, Calendar Year 
2017 File. From this dataset, I obtained the total number Medicare FFS beneficiaries 
(denominator) and then also added the total number of African American/Black Medicare FFS 
beneficiaries with the total Hispanic/Latinx Medicare FFS beneficiaries (numerator).  
Research Question 2a compared the proportion of African American/Black and 
Hispanic/Latinx beneficiaries in all MSSP ACOs compared to the proportion of African 
American/Black and Hispanic/Latinx in ACOs that achieved the highest performance (top 25% 
of scores) on the Colorectal Cancer Screening quality measure. 
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For the MSSP ACO population proportion, I extracted the same data from the 2017 
Shared Savings Program ACO PUF that was utilized in Research Question 1 and also completed 
the same calculations for the total number of MSSP ACO assigned beneficiaries and the total 
number of African American/Black and Hispanic/Latinx MSSP ACO assigned beneficiaries. 
For the top 25% of scores on the Colorectal Cancer Screening MSSP ACO population 
proportion, I also extracted data from the 2017 Shared Savings Program ACO PUF. First I sorted 
all ACOS from highest to lowest performance score for ACO 19: Colorectal Cancer Screening. 
After this sorting, I selected the highest performing ACOs by extracting the first 118 rows of 
ACOs, which is 25% of the total amount of ACOs. From this new sample of 118 ACOs, I 
calculated the total number of MSSP ACO assigned beneficiaries by adding up all of the 
numbers from the same six N_Ben_Race columns as Research Question 1 (denominator). To 
calculate the total number of African American/Black and Hispanic/Latinx MSSP ACO assigned 
beneficiaries (numerator), I added up all of the data from two columns:  N_Ben_Race_Black: 
Total assigned beneficiaries, Black) and N_Ben_Race_Hisp: Total assigned beneficiaries, 
Hispanic. 
Research Question 2b compared the proportion of African American/Black and 
Hispanic/Latinx beneficiaries in all MSSP ACOs compared to the proportion of African 
American/Black and Hispanic/Latinx in ACOs that achieved the highest performance (top 25% 
of scores) on the Breast Cancer Screening quality measure.  
For the MSSP ACO population proportion, I extracted the same data from the 2017 
Shared Savings Program ACO PUF that was utilized in Research Question 1 and 2a and also 
completed the same calculations for the total number of MSSP ACO assigned beneficiaries and 
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the total number of African American/Black and Hispanic/Latinx MSSP ACO assigned 
beneficiaries. 
For the top 25% of scores on the Colorectal Cancer Screening MSSP ACO population 
proportion, I also extracted data from the 2017 Shared Savings Program ACO PUF. First I sorted 
all ACOS from highest to lowest performance score for ACO 20: Breast Cancer Screening. After 
this sorting, I selected the highest performing ACOs by extracting the first 118 rows of ACOs, 
which is 25% of the total amount of ACOs. From this new sample of 118 ACOs, I calculated the 
total number of MSSP ACO assigned beneficiaries by adding up all of the numbers from the 
same six N_Ben_Race columns as Research Question 1 and 2a (denominator), To calculate the 
total number of African American/Black and Hispanic/Latinx MSSP ACO assigned beneficiaries 
(numerator), I added up all of the data from two columns:  N_Ben_Race_Black: Total assigned 
beneficiaries, Black and N_Ben_Race_Hisp: Total assigned beneficiaries, Hispanic. 
Chapter 4 - Results 
Research Question 1 
The hypothesis test for the first research question was the following: 
Null hypothesis (H0) = Proportion 1 (P1) < Proportion 2 (P2) 
Alternative hypothesis (Ha) = P1 > P2 
The calculation for P1 included the total number African American/Black and 
Hispanic/Latinx beneficiaries in all of Medicare FFS as the numerator and the total number of all 
beneficiaries in all of Medicare FFS as the denominator. These numbers can be found in table 2. 
The calculation for P1 was 0.1950659. 
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Table 2: 2017 Medicare FFS Proportion Data 
Total African American/Black & 
Hispanic/Latinx Medicare FFS beneficiaries 
11,403,015 
Total Medicare FFS beneficiaries 58,457,244 
 
The calculation for P2 included the total number of African American/Black and 
Hispanic/Latinx beneficiaries in all MSSP ACOs (n=472) as the numerator and the total number 
of beneficiaries in all MSSP ACOs as the denominator. These numbers can be found in table 3. 
The calculation for P2 was 0.097845119. 
Table 3: 2017 MSSP ACO Proportion Data  
Total African American/Black & 
Hispanic/Latinx beneficiaries in all MSSP 
ACOs 
879,910 
Total MSSP ACO beneficiaries 8,992,886 
 
The z-score calculated based on the two proportions (P1 and P2) was 703.28 and the 
significance level was p<0.001. Because this p-value was less than 0.05, I rejected the null 
hypothesis and I have enough evidence to support the alternative hypothesis that P1 is greater 
than P2. 
Research Question 2a 
The hypothesis test for the second research question is similar to the first research question:  
H0= P1 < P2 
Ha = P1 > P2 
The calculation for P1 was the same as the calculation for P2 in the first research question. 
These numbers can be found in table 3 and the calculation was 0.097845. 
The calculation for P2 included the total number of African American/Black and 
Hispanic/Latinx beneficiaries in the MSSP ACOs with the top of 25% of performance scores for 
colorectal cancer screening measure (n=118) as the numerator and the total number of all 
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beneficiaries in the MSSP ACOs with the top of 25% performance scores for colorectal cancer 
screening measure as the denominator. These numbers can be found in table 4. The calculation 
for P2 was 0.073337. 
Table 4: 2017 MSSP ACO Colorectal Cancer Screening Performance Proportion Data 
Total African American/Black & 
Hispanic/Latinx beneficiaries in MSSP ACOs 
with top 25% performance scores for 
colorectal cancer screening measure 
162,084 
Total MSSP ACO beneficiaries with top 25% 




The z-score calculated based on the two proportions (P1 and P2) was 112.39 and the 
significance level was p<0.001. Because this p-value was less than 0.05, I rejected the null 
hypothesis and I have enough evidence to support the alternative hypothesis that P1 is greater 
than P2. 
Research Question 2b 
The hypothesis test for the third research question is similar to the previous two research 
questions: 
H0= P1 < P2 
Ha = P1 > P2 
The calculation for P1 was the same as the calculation for P2 in the first research question 
and P1 in the second research question. These numbers can be found in table 3 and the 
calculation was 0.097845. 
The calculation for P2 included the total number of African American/Black and 
Hispanic/Latinx beneficiaries in the MSSP ACOs with the top of 25% of performance scores for 
breast cancer screening measure (n=118) as the numerator and the total number of all 
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beneficiaries in the MSSP ACOs with the top of 25% performance scores for breast cancer 
screening measure as the denominator. These numbers can be found in table 5. The calculation 
for P2 was 0.080619. 
Table 5: 2017 MSSP ACO Breast Cancer Screening Performance Proportion Data 
Total African American/Black & 
Hispanic/Latinx beneficiaries in in MSSP 
ACOs with top 25% performance scores for 
breast cancer screening measure 
183,130 
 
Total MSSP ACO beneficiaries with top 25% 
performance scores for breast cancer 




The z-score calculated based on the two proportions (P1 and P2) was 79.35 and the 
significance level was p<0.001. Because this p-value was less than 0.05, I rejected the null 
hypothesis and I have enough evidence to support the alternative hypothesis that P1 is greater 
than P2. 
Chapter 5 – Conclusion 
The principle aim of this capstone project was to understand the representation of African 
American/Black and Hispanic/Latinx beneficiaries in a fairly new widespread Medicare value-
based care program called the MSSP. To do this, I first aggregated 2017 data from two public 
datasets on racial/ethnic demographics of Medicare beneficiaries both in the entire Medicare 
system and in MSSP ACOs. Next, I calculated and tested proportions of African American/Black 
and Hispanic/Latinx beneficiaries. The results provided sufficient evidence for the following 
conclusions: 
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• The proportion of African American/Black and Hispanic/Latinx beneficiaries in 
all MSSP ACOs was lower than the proportion of African American/Black and 
Hispanic/Latinx beneficiaries in the entire Medicare FFS population. 
• The proportion of African American/Black and Hispanic/Latinx beneficiaries in 
ACOs that achieved the highest performance on Colorectal Cancer Screening and 
was lower than the proportion of African American/Black and Hispanic/Latinx 
beneficiaries in all MSSP ACOs. 
• The proportion of African American/Black and Hispanic/Latinx beneficiaries in 
ACOs that achieved the highest performance on Breast Cancer Screening and 
was lower than the proportion of African American/Black and Hispanic/Latinx 
beneficiaries in all MSSP ACOs. 
These results underscore my overall hypothesis that racial/ethnic minorities, specifically 
the two largest minority groups (African American/Black and Hispanic/Latinx), are less likely to 
be represented in MSSP ACOs, as well as represented in ACOs performing well on quality 
measures in this value-based care program, because of the current overarching disparities in 
quality of care and health outcomes that exist in these groups. Other research has shown that 
African American/Black and Hispanic/Latinxs receive less preventive care and experience higher 
incidence and mortality from chronic diseases, especially cancer, so it is understandable that they 
would not be a high proportion of beneficiaries in a federal government payer intervention 
program prioritizing and incentivizing preventive care like colorectal and breast cancer 
screenings.  
 The lower level of representation of racial/ethnic minority groups in MSSP ACOs may 
be due to the lower participation of certain types of healthcare organizations who serve more 
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racial/ethnic minority populations, such as Federally Qualified Health Centers64. These 
organizations may experience higher barriers to meet the reporting requirements of being a 
member ACO with MSSP, such as low staffing or insufficient infrastructure. Another reason 
might be that there are higher proportions of patients covered by different payers, such as 
Medicaid, served by these organizations. There are some states that offer Medicaid ACO 
programs to ensure quality and lower costs for these organizations but policy makers will need to 
consider strategies to promote more expansive participation of health care organizations that 
serve minority populations in value-based programs like the MSSP or Medicaid ACOs65.  
The results of this capstone align with the findings of other studies that have assessed 
race and ethnicity, ACO performance, and cancer screenings. The two studies mentioned 
previously did not look at the overall proportion of racial/ethnic minorities in MSSP ACOs, these 
studies provide evidence to support similar underlying ideas. The study by Lewis et al (2017) 
that found MSSP ACOs with a higher proportion of all racial/ethnic minority beneficiaries had 
worse quality performance on almost all of the MSSP ACO performance measure is similar to 
the findings of this capstone because they both support the idea that MSSP ACOs performing 
well on quality measures have less representation of racial/ethnic minorities59. The second study, 
by Wang et al (2017), which found White patients had higher colorectal cancer screening rates 
than racial/ethnic minority patients in Nebraska ACOs is similar to the findings of this capstone 
because they both support the idea that racial/ethnic minorities in ACOs are receiving less 
colorectal cancer screenings60. This was indicative in Research Question 2a of this capstone 
because racial/ethnic minorities were less representative in MSSP ACOs performing well on the 
colorectal cancer screening measures (i.e., providers are providing more colorectal cancer 
screenings).   
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Although this capstone gave a sufficient snapshot of the entire Medicare program and 
MSSP, the data analyzed in this capstone only provided a high-level view of the characteristics 
of MSSP ACOs and Medicare beneficiaries and is lacking analysis on individualized data for 
beneficiaries and ACOs. First, instead of clumping the racial/ethnic minority group together, it 
may be insightful to separately look at the proportions of African American/Black beneficiaries 
from Hispanics/Latinx when comparing the colorectal and breast cancer screenings performance 
of MSSP ACOs, since these two racial/ethnic groups have shown different incidence and 
mortality rates from colorectal and breast cancer (e.g., Black women have higher incidence and 
mortality from breast cancer). Further research and analysis should also be done on the 
characteristics of the providers and organizations providing care to the highest proportions of 
racial/ethnic minority beneficiaries. Additionally, it would be beneficial to see whether these 
providers and ACOs have the resources they need to provide preventive services, like colorectal 
and breast cancer screenings, not only to provide appropriate and necessary care to patients but 
to perform well on MSSP quality measures and be successful in the value-based care world.   
Further research should also be conducted on individual socioeconomic barriers that 
racial/ethnic minority Medicare beneficiaries face that may hinder them from receiving care 
under a MSSP ACO, even more so a high-performing MSSP ACOs. This capstone also only 
analyzed two racial/ethnic minority groups, so more expansive research should be done that not 
only includes other patient-level characteristics, like income, geographic location, or education, 
but also more racial/ethnic minority groups.  
Additionally, this is only data on Medicare and MSSP, so the findings of this capstone 
cannot be generalized to other patients with different types of health insurance coverage or 
receiving care under different value-based care programs. To broaden the scope of understanding 
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the Reach for racial/minority patients, additional research should be done to analyze the 
representation of racial/ethnic minorities under different value-based care programs, as these 
program are not just existent in Medicare and are progressively being administered in the 
Medicaid and private payer spaces. 
The information from this capstone on the Reach of the MSSP among African 
American/Black and Hispanic/Latinxs Medicare beneficiaries may be helpful for researchers, 
policy makers, and health care organizations in addressing obstacles that may be influencing 
racial/ethnic minority beneficiaries not to participate or receive care from an MSSP ACO or 
other value-based care delivery and payment programs, which are rapidly appearing within the 
U.S. health care system. Ensuring appropriate representativeness of racial/ethnic minorities in 
these value-based programs may encourage equitable access to effective, high-quality, less costly 
health care for all, regardless of race/ethnicity. It is the hope that this will steer us in a direction 
that eradicates differences in care and health outcomes that unjustly exist within the racial/ethnic 
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Minor: Anthropology 
 
Thesis: “Socioecological Impacts on Malaria Transmission: A Systematic Review and Citation 
Network Analysis” (Advisors: Dr. Kirk Dombrowski and Dr. Lisa Kort-Butler) 
 
Member of Alpha Kappa Delta International Sociology Honor Society 
 
Member of Omicron Delta Kappa National Senior Honor Society 





Health Policy Analyst        August 2018 - Present 
Novant Health, Winston-Salem, NC 
• Summarize proposed and final state and federal regulations in oral and written 
deliverables for internal leaders to understand, strategize, and operate effectively within 
the changing health care policy environment 
• Develop internal educational materials, such as a policy e-newsletter, issue briefs, and 
white papers, to identify and share key regulatory, legislative, and industry initiatives 
• Collaborate with the government relations team to share information with internal leaders 
and external policy makers as it relates to health care services  
Research Compliance Services Specialist              September 2015 – July 2018 
Student Worker          September 2014 – September 2015 
UNL Office of Research and Economic Development, Lincoln, NE  
 
• Administer procedures for the UNL Human Research Protection Program, as mandated 
by the U.S. Department of Health and Human Services (DHHS) Office of Human 
Research Protections, to ensure that UNL faculty, staff, and students are conducting 
university human subjects research in compliance with federal, state, and university 
policies and regulations 
• Work with grant liaisons and conduct grant congruency reviews to ensure submitted 
research projects are consistent with what is described in applicable proposal documents 
provided to the awarding agencies 
• Sustain communication with research investigators and provide campus trainings and 
educational sessions to promote a culture of ethical standards and regulatory compliance 
• Plan, facilitate, and document monthly Institutional Review Board meetings 
• Participate in developing and maintaining institutional policies, standard operating 
procedures, and guidance documents to ensure Research Compliance Services and the 
UNL campus community are upholding organized operations 
 
Temporary Project Assistant                 May 2015 – September 2015 
UNL Social and Behavioral Sciences Research Consortium, Lincoln, NE 
 
• Assist in the creation of a supplement report for the 2015 Nebraska Statewide Health 
Improvement Plan in collaboration with the Nebraska DHHS Office of Community and 
Rural Health 
• Use Microsoft Excel and Word to summarize and formulate figures of state data  
 
Human Resources Coordinator           May 2013 - January 2014 
The Lincoln Marriott Cornhusker Hotel, Lincoln, NE 
 
• Facilitate recruitment and hiring procedures for all hotel positions, such as reviewing job 
applications, completing phone screening, and conducting onboarding procedures. 
L. Arneson   Capstone (CPH 529) - Fall 2019 
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• Ensure proper policies, procedures, and reporting are applied to comply with federal, 
state, local, and corporate policies 
• Manage confidential associate information in both the computer system and physical files 




• Certified IRB Professional, Public Responsibility in Medicine and Research 
September 2017 – December 2020 
• Health Navigation/Community Health Worker Course, Nebraska DHHS  
August 2017 – January 2018 
 
Volunteer & Leadership Experience 
 
• Flourish Program Mentor, The Shalom Project 
May 2019 - Present 
• Member, The Women’s Fund of Winston-Salem Research, Education, and Advocacy 
Committee 
February 2019 - Present 
• Student Member, Public Health Association of Nebraska 
January 2018 – January 2019 
• Refugee Family Mentor, Lutheran Family Services of Nebraska, Inc.  
Fall 2016 – Present 
• Four Directions Youth Program Assistant, Indian Center, Inc. of Lincoln, Nebraska  
January 2014 – May 2014 
• Vice President of Organization, Sigma Chapter of Kappa Kappa Gamma Fraternity 
January 2013 – December 2013 
• Vice President of Academic Excellence, Sigma Chapter of Kappa Kappa Gamma 
Fraternity 
January 2012 – December 2012 
 
 
 
 
 
 
 
 
 
